Marshall Wace, LLP Eq Rx, Inc. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $921,942 - $1.28 Million	555,387 New	555,387 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.69 $229,782 - $408,581	-71,807 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $42,739 - $112,800	15,264 Added 27.0%	71,807 $298,000
Q4 2021 Feb 14, 2022	BUY	$5.92 - $9.98 $334,734 - $564,299	56,543 New	56,543 $385,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.